Authors
1 Dept. Artificial Insemination and Embryo Transfer, Animal Reproduction Research Institute, Agriculture Research center
2 Dept. Biology of Reproduction, Animal Reproduction Research Institute, Agriculture Research center
Abstract
Keywords
THE EFFECT OF OXYTOCIN, PROSTAGLANDIN F2a OR GNRH INJECTION ON FRESH AND FROZEN-THAWED SEMEN CHARACTERISTICS OF RAMS
EL-BADRY D.A.*; FATEN I. GABR** and MONA H. SHAKER*
*Dept. Artificial Insemination and Embryo Transfer, Animal Reproduction Research Institute, Agriculture Research center
**Dept. Biology of Reproduction, Animal Reproduction Research Institute, Agriculture Research center
|
ABSTRACT
|
Received at: 30/6/2013
Accepted: 25/8/2013 |
The present study aimed to maximize the semen output from rams using oxytocin, prostaglandin F2α (PG F2α) or gondatrophin releasing hormone (GnRH) as well as to study the effects of these treatments on quality, freezability and antioxidant activity of ram semen. In the present work, 4 groups (each containing 3 Barki rams) were used as; control (group 1) injected with normal saline intramuscularly (i.m.) 30 min. prior to semen collection, group 2 injected with 10 i.u. oxytocin intravenously (i.v.) 10 min. prior to semen collection, group3 injected with 250 µg of cloprostenol i.m. 30 min. before semen collection and group 4 injected with 50 µg of gonadorelin i.v. 60minutes before semen collection. Two ejaculates were collected from rams of all groups once weekly for 10 successive weeks. At the 1st, 5th and 10th week semen samples were processesed for cryopreservation and testosterone and antioxidant enzymes were measured in the separated seminal plasma. Results indicated that both PG F2α and oxytocin resulted in significant (P ≤ 0.05) increase in semen volume and total number of spermatozoa per ejaculates allover the experimental period without altering the quality of the fresh ejaculated or the frozen-thawed semen. Also, PG F2α and oxytocin had no undesirable effect on testosterone level and the values of total antioxidants, superoxide dismutase and glutathione peroxidase in seminal plasma. On the other hand, GnRH elevated the level of testosterone but did not increase the sperm output in rams. Conclusively, repeated injection of PGF2α andoxytocinprior to semen collection was found to be useful when collecting ram semen for use in artificial insemination as they increase the sperm output without altering the quality of fresh or frozen-thawed semen as well as they have no deleterious effects on the antioxidant activities of seminal plasma and testosterone level in rams.
|
Key words: Oxytocin, Prostaglandin F2α, Rams.
|
INTRODUCTION
Nowadays increasing use of assisted reproductive techniques in sheep has uncovered a need for additional aids to help veterinarians for optimizing the ejaculates obtained from rams. Specifically, improving upon the number of spermatozoa obtained during semen collection would benefit most areas of assisted reproduction, including semen cryopreservation and artificial insemination. Oxytocin treatment prior to semen collection resulted in increased sperm output in rams (Nicholson et al., 1999; Bozkurt et al., 2007), buffalos(Ibrahim, 1988) bulls (Berndtson and Igboeli, 1988; Palmer et al., 2004) and rabbits (Fjellstrom et al., 1968). Therefore, it seems reasonable that since oxytocin is involved in the transit of sperm through the male duct system, it may hasten ejaculation in rams. Oxytocin may be involved in the movement of sperm in the male duct system, specifically; epididymal sperm transport (Whittington et al., 2001).Oxytocin receptors have been isolated from the epididymal smooth muscle of several species (Frayne and Nicholson, 1998; Whittington et al., 2001) and in vitro and in vivo studies in rodents have shown that oxytocin increased contractility of the epididymis (Hib, 1977). Furthermore, sexual stimulation and ejaculation were associated with a concurrent rise in blood oxytocin concentration in many species (Murphy et al., 1987).
PG F2α is known to increase smooth muscle contractility in the male and female genital tracts and may be involved in the ejaculation process(Bygdeman, 1981). Parenteral PGF2α administration before semen collection resulted in increased sperm output in stallions (Cornwell et al., 1974; McDonnell, 1992), dogs (Hess, 2001), and buffalo (Ibrahim, 1988). However, the effect of PG F2α treatment on sperm output in the bull is contradictory, with one study reporting increased sperm output after treatment (Marshall and Hafs, 1976)and a second experiment reporting no treatment effect (Berndtson et al., 1979).
Administration of exogenous GnRH to male dogs induces a dose dependent release of LH immediately following treatment with a resultant increase in testosterone concentration starting 10 minutes after GnRH administration, peak in 50-60 minutes and remains elevated above control values for 4-24 hours (Knol et al., 1993; Hess, 2002). Gabor et al. (1995) found that repeated injection of GnRH resulted in higher level of testosterone hormone in bulls.
The present study attempts to evaluate the effects of oxytocin, PGF2a and GnRH injection prior to semen collection on fresh and frozen-thawed semen characteristics of rams.
MATERIALS and METHODS
Animals and treatment:
Twelve mature, clinically healthy Barki rams, aged 1.5-2.5 years were assigned to the study. Rams were kept in the experimental farm of the Animal Reproduction Research Institute (ARRI), and they were divided into four groups (each containing 3 rams); group 1 (control, injected intramuscularly with 2 ml normal saline 30 minutes prior to semen collection), group 2 (injected with 10 i.u. oxytocin i.v. “Oxytocin, Bela-pharm, Germany”, , 10minutes before semen collection “Knight, 1974”), group 3 (injected i.m. with 250 µg of cloprostenol “Estrumate; Schering Plough Animal Health, Germany” 30 minutes before semen collection “Mekonnen et al., 1989”) and group 4 (injected i.v. with 50 µg of the GnRH analogue, gonadorelin diacetate tetrahydrate “Cystorelin; CEVA Sante Animale, France” , 60minutes before semen collection “Hess, 2002”).
Semen collection and evaluation:
Semen samples were collected from rams of all groups using artificial vagina that was adjusted to a proper condition. Two ejaculates were collected once weekly for 10 successive weeks. Immediately after collection samples were evaluated for mass activity and individual motility using a pre-warmed stage of phase contrast microscope. Two smears of the semen, stained with eosin– nigrosin, were prepared (Blom, 1950)and used to determine the percentage of both live and morphologically abnormal spermatozoa (Bielanski et al., 1982). Sperm concentration was measured with hemocytometer.
Seminal plasma samples:
Seminal plasma samples were obtained at the 1st, 5th and 10th week by centrifugation of portion of semen samples at 3000 rpm for 10 minutes. Supernatant was passed through 1.2 µm nylon syringe filters to obtain sperm-free seminal plasma and stored at -80 oC. Testosterone was measured in seminal plasma samples by ELISA reader in duplicate, at 450 nm wavelength according to Maruyama (1987). The total antioxidant level was measured spectrophotometrically in seminal plasma samples at 37 oC and 421 nm according to Koracevic and Koracevic (2001), the superoxide dismutase level was measured at 560 nm according to Nishikimi et al. (1972), while the glutathione peroxidase level was measured at 430 nm according to Paglia and Valentine (1967).
Cryopreservation of ram semen:
Semen samples that collected from all groups at the 1st, 5th and 10th week were diluted at a ratio of 1:19 at 30oC with Tris based extender (Evans and Maxwell, 1986).After that, the extended semen was cooled to 5oC throughout 60 minutes in a cold handling cabinet. The cooled semen was loaded into 0.25 ml French straws (IMV, L'Aigle, France), arranged horizontally on a cooled racks, then lowered into liquid nitrogen vapor inside foam box (Khalifa, 2001).Then the straws were immersed in liquid nitrogen and stored.
Evaluation of cryopreserved semen:
One week after cryopreservation, frozen ram semen samples were thawed in water bath at 37oC for 30 seconds. Individual sperm motility was subjectively assessed post thawing and after 1, 2 and 3 hours of thawing. The post-thawing viability indices were estimated according to Milovanov (1962).The percentage of abnormal acrosome was recorded after thawing in smears stained by fast green FCF (Wells and Awa, 1970).
Statistical analysis:
Two way analysis of variance and Duncan’s multiple range tests were done for the data obtained. Such statistical analysis was performed according toCostat computer program copyright (1986).
RESULTS
As shown in table 1, injection of oxytocin and PGF2α resulted in a significantly (P ≤ 0.05) higher total semen volume of the 1st and 2nd ejaculates (2.84 ± 0.06 and 2.62 ± 0.06 ml, respectively) when compared with the control and GnRH groups (2.17 ± 0.06 and 2.24 ± 0.04 ml, respectively).
Table 1: Effect of injection of oxytocin, PGF2α and GnRH on semen volume in rams (Mean ± S.D.).
Weeks |
Semen volume (ml) |
|||||||||||
First ejaculate |
Second ejaculate |
Total |
||||||||||
Gp 1 |
Gp 2 |
Gp 3 |
Gp 4 |
Gp 1 |
Gp 2 |
Gp 3 |
Gp 4 |
Gp 1 |
Gp 2 |
Gp 3 |
Gp 4 |
|
1 |
1.00 ±0.15 |
1.53 ±0.09 |
1.33 ±0.09 |
1.03 ±0.09 |
1.03 ±0.18 |
1.10 ±0.06 |
1.13 ±0.09 |
1.17 ±0.03 |
2.03 ±0.33 |
2.63 ±0.07 |
2.47 ±0.18 |
2.20 ±0.10 |
2 |
1.03 ±0.09 |
1.60 ±0.06 |
1.27 ±0.03 |
1.23 ±0.15 |
1.23 ±0.09 |
1.33 ±0.12 |
1.17 ±0.12 |
1.30 ±0.12 |
2.27 ±0.19 |
2.73 ±0.19 |
2.43 ±0.13 |
2.53 ±0.12 |
3 |
1.23 ±0.14 |
1.93 ±0.09 |
1.60 ±0.06 |
1.27 ±0.17 |
1.10 ±0.10 |
1.33 ±0.07 |
1.23 ±0.12 |
1.13 ±0.09 |
2.33 ±0.02 |
3.27 ±0.33 |
2.83 ±0.09 |
2.40 ±0.17 |
4 |
0.97 ±0.09 |
1.47 ±0.14 |
1.00 ±0.15 |
1.10 ±0.06 |
1.07 ±0.13 |
1.03 ±0.09 |
1.07 ±0.07 |
10.03 ±0.09 |
2.03 ±0.14 |
2.50 ±0.20 |
2.07 ±0.22 |
2.17 ±0.33 |
5 |
0.93 ±0.09 |
1.60 ±0.06 |
1.30 ±0.06 |
0.97 ±0.09 |
1.03 ±0.03 |
1.03 ±0.12 |
1.07 ±0.09 |
1.10 ±0.15 |
1.97 ±0.06 |
2.63 ±0.12 |
2.37 ±0.14 |
2.07 ±0.14 |
6 |
0.93 ±0.03 |
1.70 ±0.06 |
1.43 ±0.03 |
0.90 ±0.17 |
1.01 ±0.06 |
1.00 ±0.06 |
1.17 ±0.09 |
1.13 ±0.12 |
2.03 ±0.09 |
2.70 ±0.06 |
2.60 ±0.06 |
2.03 ±0.22 |
7 |
1.07 ±0.14 |
1.67 ±0.12 |
1.36 ±0.03 |
1.00 ±0.17 |
1.23 ±0.14 |
1.30 ±0.10 |
1.40 ±0.15 |
1.23 ±0.17 |
2.30 ±0.29 |
2.97 ±0.22 |
2.77 ±0.17 |
2.23 ±0.09 |
8 |
1.17 ±0.09 |
1.70 ±0.03 |
1.50 ±0.09 |
1.07 ±0.12 |
1.23 ±0.06 |
1.27 ±0.09 |
1.37 ±0.09 |
1.30 ±0.06 |
2.40 ±0.15 |
2.97 ±0.14 |
2.87 ±0.07 |
2.13 ±0.12 |
9 |
1.07 ±0.09 |
1.87 ±0.12 |
1.60 ±0.06 |
0.97 ±0.07 |
1.10 ±0.06 |
1.30 ±0.21 |
1.33 ±0.21 |
1.17 ±0.09 |
2.17 ±0.13 |
3.17 ±0.18 |
2.93 ±0.06 |
2.13 ±0.12 |
10 |
1.03 ±0.09 |
1.70 ±0.12 |
1.37 ±0.07 |
1.03 ±0.12 |
1.13 ±0.09 |
1.10 ±0.21 |
1.47 ±0.09 |
1.20 ±0.06 |
2.17 ±0.13 |
2.80 ±1.52 |
2.83 ±0.13 |
2.23 ±0.12 |
Mean |
1.04c ±0.03 |
1.68 a ±0.04 |
1.38 b ±0.04 |
1.06 c ±0.03 |
1.13 a ±0.03 |
1.16 a ±0.04 |
1.24 a ±0.04 |
1.18 a ±0.03 |
2.17 c ±0.06 |
2.84 a ±0.06 |
2.62 b ±0.06 |
2.24 c ±0.04 |
Gp 1: Conrol, Gp2: oxytocin, Gp 3: PGF2α and Gp4: GnRH.
Data regarding the ram sperm concentration were represented in table 2. Injecting rams with PGF2α prior to semen collection resulted in a significant (P ≤ 0.05) increase in sperm cell concentration when compared to control (2.50 ± 0.04 vs. 2.33 ± 0.05 x109 sperm/ml, respectively). On the other hand, there were no statistically significant differences (P ≤ 0.05) between oxytocin and GnRH groups (2.29 ± 0.05 and 2.23 ± 0.06 x 109 sperm/ml, respectively) as compared with control group.
Table 2: Effect of injection of oxytocin, PGF2α and GnRH on sperm concentration in rams (Mean ± S.D.).
Weeks |
Sperm concentration (x109 /ml) |
|||||||||||
First ejaculate |
Second ejaculate |
Average |
||||||||||
Gp 1 |
Gp 2 |
Gp 3 |
Gp 4 |
Gp 1 |
Gp 2 |
Gp 3 |
Gp 4 |
Gp 1 |
Gp 2 |
Gp 3 |
Gp 4 |
|
1 |
2.06 ±0.03 |
2.44 ±0.05 |
2.34 ±0.09 |
2.25 ±0.05 |
2.06 ±0.14 |
1.97 ±0.05 |
2.38 ±0.11 |
2.16 ±0.09 |
2.12 ±0.09 |
2.20 ±0.01 |
2.36 ±0.02 |
2.21 ±0.04 |
2 |
1.94 ±0.02 |
2.07 ±0.04 |
2.15 ±0.05 |
1.91 ±0.02 |
2.04 ±0.17 |
1.77 ±0.07 |
2.42 ±0.06 |
1.79 ±0.32 |
1.99 ±0.09 |
1.92 ±0.02 |
2.29 ±0.03 |
1.85 ±0.15 |
3 |
2.34 ±0.10 |
2.45 ±0.06 |
2.23 ±0.03 |
2.18 ±0.06 |
2.35 ±0.20 |
2.31 ±0.01 |
2.56 ±0.10 |
2.51 ±0.21 |
2.34 ±0.10 |
2.38 ±0.03 |
2.40 ±0.03 |
2.35 ±0.08 |
4 |
2.43 ±0.11 |
2.56 ±0.06 |
2.43 ±0.06 |
1.55 ±0.11 |
2.38 ±0.11 |
2.15 ±0.09 |
2.70 ±0.09 |
1.89 ±0.14 |
2.41 ±0.11 |
2.35 ±0.12 |
2.57 ±0.04 |
1.92 ±0.12 |
5 |
2.83 ±0.06 |
3.11 ±0.12 |
2.72 ±0.04 |
2.54 ±0.06 |
2.61 ±0.35 |
2.43 ±0.05 |
2.96 ±0.07 |
2.67 ±0.32 |
2.72 ±0.16 |
2.77 ±0.09 |
2.38 0.05 |
2.61 ±0.13 |
6 |
2.19 ±0.10 |
2.75 ±0.08 |
2.48 ±0.05 |
2.35 ±0.02 |
2.18 ±0.23 |
2.35 ±0.10 |
2.68 ±0.27 |
2.20 ±0.32 |
2.19 ±0.16 |
2.55 ±0.09 |
2.58 ±0.13 |
2.28 ±0.13 |
7 |
2.26 ±0.05 |
2.34 ±0.05 |
2.42 ±0.07 |
2.56 ±0.21 |
2.39 ±0.23 |
2.17 ±0.03 |
2.59 ±0.28 |
2.68 ±0.30 |
2.32 ±0.12 |
2.26 ±0.04 |
2.51 ±0.15 |
2.62 ±0.25 |
8 |
2.75 ±0.08 |
2.64 ±0.10 |
2.47 ±0.05 |
2.22 ±0.06 |
2.65 ±1.53 |
2.16 ±0.10 |
2.88 ±0.19 |
2.43 ±0.26 |
2.70 ±0.06 |
2.40 ±0.10 |
2.68 ±0.11 |
2.33 ±0.11 |
9 |
2.15 ±0.03 |
2.27 ±0.04 |
2.23 ±0.07 |
2.05 ±0.12 |
2.17 ±0.16 |
1.77 ±0.06 |
2.51 ±0.24 |
2.27 ±0.35 |
2.16 ±0.07 |
2.02 ±0.05 |
2.37 ±0.09 |
2.16 ±0.14 |
10 |
2.27 ±0.05 |
2.22 ±0.05 |
2.35 ±0.05 |
1.76 ±0.11 |
2.33 ±0.05 |
1.93 ±0.03 |
2.41 ±0.26 |
2.14 ±0.05 |
2.30 ±0.05 |
2.08 ±0.05 |
2.38 ±0.14 |
1.95 ±0.08 |
Mean |
2.33 b ±0.05 |
2.49 a ±0.06 |
2.38 b ±0.03 |
2.18 c ±0.05 |
2.32 b ±0.06 |
2.10 c ±0.05 |
2.61 a ±0.06 |
2.28 b ±0.09 |
2.33 b ±0.05 |
2.29 b ±0.05 |
2.50 a ±0.04 |
2.23 b ±0.06 |
Gp 1: Conrol, Gp2: oxytocin, Gp 3: PGF2α and Gp4: GnRH.
Table 3 illustrates the effect of different treatments on the total number of spermatozoa per ejaculates. Injection of oxytocin and PGF2α significantly (P ≤ 0.05) increased the total number of spermatozoa per ejaculates as compared with control group (6.59 ± 0.18 and 5.74 ± 0.17 vs. 5.29 ± 0.17 x 109, respectively). In contrary, the GnRH group had the lowest total number of spermatozoa per ejaculates (4.86 ± 0.14 x 109).
Table 3: Effect of injection of oxytocin, PGF2α and GnRH on total number of spermatozoa per ejaculates in rams (Mean ± S.D.).
Weeks |
Total number of spermatozoa (x109) |
|||||||||||
First ejaculate |
Second ejaculate |
Total |
||||||||||
Gp 1 |
Gp 2 |
Gp 3 |
Gp 4 |
Gp 1 |
Gp 2 |
Gp 3 |
Gp 4 |
Gp 1 |
Gp 2 |
Gp 3 |
Gp 4 |
|
1 |
2.16 ±0.30 |
3.75 ±0.27 |
3.11 ±0.13 |
2.33 ±0.24 |
2.38 ±0.42 |
2.17 ±0.17 |
2.31 ±0.13 |
2.64 ±0.16 |
4.55 ±0.57 |
5.92 ±0.14 |
5.42 ±0.40 |
4.98 ±0.22 |
2 |
2.00 ±0.16 |
3.30 ±0.06 |
2.72 ±0.10 |
2.36 ±0.19 |
2.79 ±0.25 |
2.03 ±0.29 |
2.18 ±0.30 |
2.65 ±0.51 |
4.79 ±0.15 |
5.33 ±0.38 |
5.90 ±0.38 |
5.02 ±0.216 |
3 |
2.85 ±0.21 |
4.75 ±0.30 |
3.57 ±0.16 |
2.78 ±0.44 |
3.00 ±0.25 |
3.08 ±0.14 |
2.37 ±0.19 |
2.87 ±0.24 |
5.85 ±0.46 |
7.83 ±0.14 |
5.94 ±0.14 |
5.65 ±0.24 |
4 |
2.37 ±0.33 |
3.76 ±0.42 |
2.43 ±0.37 |
2.14 ±0.12 |
2.71 ±0.59 |
2.20 ±0.14 |
1.97 ±0.15 |
2.23 ±0.17 |
5.08 ±0.47 |
5.96 ±0.57 |
4.39 ±0.65 |
4.37 ±0.23 |
5 |
2.64 ±0.22 |
4.99 ±0.22 |
3.53 ±0.14 |
2.47 ±0.28 |
3.28 ±0.11 |
2.51 ±0.17 |
2.38 ±0.17 |
3.22 ±0.44 |
5.91 ±0.03 |
7.50 ±0.54 |
5.91 ±0.31 |
5.69 ±0.24 |
6 |
2.05 ±0.16 |
4.68 ±0.28 |
3.55 ±0.04 |
2.11 ±0.23 |
2.64 ±0.14 |
2.35 ±0.14 |
2.57 ±0.27 |
2.07 ±0.21 |
4.69 ±0.43 |
7.03 ±0.33 |
6.13 ±0.32 |
4.18 ±0.70 |
7 |
2.42 ±0.38 |
3.89 ±0.20 |
3.31 ±0.13 |
2.49 ±0.24 |
3.26 ±0.31 |
2.82 ±0.18 |
2.85 ±0.36 |
2.62 ±0.37 |
5.69 ±0.91 |
6.71 ±0.37 |
6.16 ±0.81 |
5.11 ±0.58 |
8 |
3.20 ±0.16 |
4.48 ±0.42 |
3.70 ±0.11 |
2.37 ±0.11 |
3.27 ±0.14 |
2.75 ±0.32 |
2.70 ±0.23 |
2.77 ±0.20 |
6.47 ±0.29 |
7.23 ±0.55 |
6.40 ±0.39 |
5.14 ±0.27 |
9 |
2.30 ±0.21 |
4.25 ±0.33 |
3.57 ±0.23 |
1.97 ±0.07 |
2.59 ±0.07 |
2.29 ±0.37 |
2.62 ±0.07 |
2.19 ±0.20 |
4.89 ±0.29 |
6.54 ±0.45 |
6.19 ±0.23 |
4.16 ±0.55 |
10 |
2.34 ±0.14 |
3.76 ±0.17 |
3.20 ±0.09 |
1.79 ±0.12 |
2.63 ±0.20 |
2.13 ±0.42 |
2.73 ±0.07 |
2.58 ±0.16 |
4.97 ±0.23 |
5.90 ±0.09 |
5.93 ±0.11 |
4.37 ±0.17 |
Mean |
2.43 c ±0.09 |
4.16 a ±0.12 |
3.27 b ±0.09 |
2.28 c ±0.08 |
2.85 a ±0.09 |
2.43 b ±0.09 |
2.47 b ±0.07 |
2.58 b ±0.10 |
5.29 c ±0.17 |
6.59 a ±0.18 |
5.74 b ±0.17 |
4.86 d ±0.14 |
Gp 1: Conrol, Gp2: oxytocin, Gp 3: PGF2α and Gp4: GnRH.
Regarding the total number of motile spermatozoa per ejaculates (table 4), the oxytocin group had the highest one (5.15 ± 0.16 x 109) as compared with control, PGF2α and GnRH groups (4.34 ± 0.14, 4.34 ± 0.12 and 4.14 ± 0.13 x 109, respectively).
Table 4: Effect of injection of oxytocin, PGF2α and GnRH on mass activity of spermatozoa and total number of motile spermatozoa in rams per ejaculates (Mean ± S.D.).
Weeks |
Spermatozoal Mass Activity |
Total number of motile spermatozoa (x 109) |
||||||||||
First ejaculate |
Second ejaculate |
|||||||||||
Gp 1 |
Gp 2 |
Gp 3 |
Gp 4 |
Gp 1 |
Gp 2 |
Gp 3 |
Gp 4 |
Gp 1 |
Gp 2 |
Gp 3 |
Gp 4 |
|
1 |
+++ |
+++(+) |
+++ |
+++ |
+++ |
+++(+) |
+++ |
++++ |
3.64 ±0.45 |
4.85 ±0.38 |
4.33 ±0.25 |
4.15 ±0.23 |
2 |
+++ |
+++(+) |
+++ |
+++ |
+++ |
+++(+) |
+++ |
++++ |
3.95 ±0.27 |
4.34 ±0.28 |
3.96 ±0.28 |
4.10 ±0.09 |
3 |
+++ |
+++ |
+++ |
+++(+) |
+++(+) |
+++(+) |
++(+) |
+++(+) |
4.79 ±0.42 |
6.45 ±0.16 |
4.31 ±0.18 |
4.75 ±0.21 |
4 |
+++(+) |
+++ |
+++(+) |
+++(+) |
+++(+) |
+++ |
+++ |
+++ |
4.28 ±0.42 |
5.03 ±0.58 |
3.59 ±0.55 |
3.68 ±0.17 |
5 |
+++(+) |
+++ |
+++ |
+++ |
+++ |
+++ |
+++ |
+++ |
4.83 ±0.2.89 |
6.08 ±0.55 |
4.60 ±0.43 |
4.72 ±0.17 |
6 |
+++ |
+++ |
+++ |
++++ |
+++ |
+++ |
+++ |
++++ |
3.80 ±0.38 |
5.56 ±0.37 |
4.70 ±0.24 |
3.70 ±0.62 |
7 |
+++(+) |
+++ |
++(+) |
+++(+) |
+++(+) |
+++ |
++(+) |
+++(+) |
4.61 ±0.80 |
4.97 ±0.27 |
4.45 ±0.51 |
4.47 ±3.33 |
8 |
+++ |
+++ |
+++ |
++++ |
+++ |
+++ |
+++ |
++++ |
5.33 ±0.25 |
5.25 ±0.42 |
4.89 ±0.19 |
4.50 ±0.32 |
9 |
+++(+) |
++(+) |
++(+) |
+++(+) |
+++(+) |
++(+) |
++(+) |
+++(+) |
4.11 ±0.13 |
4.68 ±0.33 |
4.34 ±0.14 |
3.56 ±0.34 |
10 |
+++ |
+++ |
+++ |
+++(+) |
+++ |
+++ |
+++ |
+++(+) |
4.02 ±0.21 |
4.32 ±0.32 |
4.25 ±0.19 |
3.82 ±0.10 |
Mean |
+++ b |
+++ b |
+++ b |
+++(+)a |
+++(+)a |
+++ b |
+++ b |
+++(+)a |
4.34 b ±0.14 |
5.15 a ±0.16 |
4.34 b ±0.12 |
4.14 b ±0.13 |
Gp 1: Conrol, Gp2: oxytocin, Gp 3: PGF2α and Gp4: GnRH.
As demonstrated in tables 4 and 5, injection of GnRH resulted in the highest (P ≤ 0.05) mass and individual motility of spermatozoa (+++[+] and 8.33 ± 0.61%). On the other hand, injection of oxytocin and PGF2α resulted in a significantly (P ≤ 0.05) lower spermatozoa individual motility as compared with control group (78.17 ± 1.08 and 76.00 ± 0.85% vs. 81.92 ± 0.57%, respectively).
Table 5: Effect of injection of oxytocin, PGF2α and GnRH on Sperm individual motility in rams (Mean ± S.D.).
Weeks |
Sperm individual motility |
|||||||||||
First ejaculate |
Second ejaculate |
Mean |
||||||||||
Gp 1 |
Gp 2 |
Gp 3 |
Gp 4 |
Gp 1 |
Gp 2 |
Gp 3 |
Gp 4 |
Gp 1 |
Gp 2 |
Gp 3 |
Gp 4 |
|
1 |
78.33 ±1.67 |
81.67 ±6.01 |
78.33 ±1.67 |
81.67 ±1.67 |
81.67 ±1.67 |
81.67 ±3.33 |
81.67 ±1.67 |
85.00 ±2.89 |
80.00 ±0.00 |
81.67 ±4.64 |
80.00 ±1.44 |
83.33 ±3.82 |
2 |
81.67 ±1.67 |
81.67 ±3.33 |
81.67 ±1.67 |
81.67 ±1.67 |
83.33 ±1.67 |
81.67 ±1.67 |
80.00 ±0.00 |
81.67 ±1.67 |
82.50 ±0.00 |
81.67 ±2.21 |
80.83 ±0.83 |
81.67 ±0.83 |
3 |
80.00 ±2.89 |
81.67 ±1.67 |
73.33 ±1.67 |
83.33 ±3.33 |
83.33 ±1.67 |
83.33 ±3.33 |
71.67 ±1.67 |
85.00 ±0.00 |
81.67 ±2.21 |
82.50 ±2.50 |
72.50 ±1.44 |
84.17 ±0.83 |
4 |
80.00 ±2.89 |
81.67 ±1.67 |
83.33 ±1.67 |
83.33 ±1.67 |
83.33 ±1.67 |
83.33 ±1.67 |
81.67 ±2.89 |
85.00 ±2.89 |
84.17 ±2.21 |
84.17 ±1.67 |
81.67 ±1.67 |
83.33 ±1.67 |
5 |
83.33 ±1.67 |
81.67 ±1.67 |
78.33 ±1.67 |
81.67 ±1.67 |
80.00 ±2.89 |
80.00 ±2.89 |
76.67 ±4.41 |
85.00 ±2.89 |
81.67 ±2.21 |
80.83 ±2.21 |
77.50 ±2.89 |
83.33 ±1.67 |
6 |
78.33 ±1.67 |
78.33 ±4.41 |
76.67 ±1.67 |
83.33 ±1.67 |
83.33 ±1.67 |
80.00 ±2.89 |
76.67 ±1.67 |
88.33 ±1.67 |
80.83 ±1.67 |
79.17 ±3.63 |
76.67 ±0.83 |
83.33 ±0.83 |
7 |
81.67 ±4.41 |
75.00 ±2.89 |
71.67 ±1.67 |
86.67 ±1.67 |
80.00 ±2.89 |
73.33 ±3.33 |
73.33 ±1.67 |
88.33 ±1.67 |
80.83 ±3.00 |
74.17 ±3.00 |
72.50 ±1.44 |
87.50 ±0.00 |
8 |
81.67 ±1.67 |
73.33 ±1.67 |
76.67 ±1.67 |
83.33 ±1.67 |
83.33 ±1.67 |
71.67 ±1.67 |
76.67 ±3.33 |
86.67 ±1.67 |
82.50 ±1.44 |
72.50 ±1.44 |
76.67 ±2.21 |
87.50 ±1.44 |
9 |
85.00 ±2.89 |
71.67 ±1.67 |
68.33 ±1.67 |
86.67 ±3.33 |
83.33 ±1.67 |
71.67 ±1.67 |
71.67 ±1.67 |
85.00 ±2.89 |
84.17 ±2.21 |
71.67 ±1.67 |
70.00 ±1.44 |
85.83 ±3.00 |
10 |
80.00 ±2.89 |
75.00 ±2.89 |
71.67 ±1.67 |
86.67 ±1.67 |
81.67 ±1.67 |
71.67 ±1.67 |
71.67 ±1.67 |
83.33 ±1.67 |
80.83 ±2.21 |
73.33 ±2.21 |
71.67 ±2.21 |
87.50 ±1.44 |
Mean |
81.50b ±0.80 |
78.50c ±1.15 |
75.83d ±0.93 |
84.83a ±0.74 |
82.33b ±0.57 |
77.83c ±1.12 |
76.17c ±0.92 |
85.83a ±0.68 |
81.92b ±0.57 |
78.17c ±1.08 |
76.00d ±0.85 |
85.33a ±0.61 |
Gp 1: Conrol, Gp2: oxytocin, Gp 3: PGF2α and Gp4: GnRH.
Table 6 illustrates the effect of different treatments on the ram sperm viability. Injection of GnRH prior to semen collection resulted in the highest (P ≤ 0.05) sperm viability (87.17 ± 0.58%) as compared with control group. On the other hand, injection of oxytocin and PGF2α resulted in a significantly (P ≤ 0.05) lower sperm viability as compared with control group (80.43 ± 1.04 and 78.30 ± 0.84 vs. 84.08 ± 0.57%, respectively).
Table 6: Effect of injection of oxytocin, PGF2α and GnRH on spermatozoa viability in rams (Mean ± S.D.).
Weeks |
Spermatozoal viability (% of live spermatozoa) |
|||||||||||
First ejaculate |
Second ejaculate |
Mean |
||||||||||
Gp 1 |
Gp 2 |
Gp 3 |
Gp 4 |
Gp 1 |
Gp 2 |
Gp 3 |
Gp 4 |
Gp 1 |
Gp 2 |
Gp 3 |
Gp 4 |
|
1 |
81.33 ±2.19 |
84.00 ±6.25 |
81.00 ±1.53 |
84.00 ±2.08 |
83.67 ±1.67 |
83.67 ±3.38 |
83.33 ±1.85 |
86.33 ±2.90 |
82.50 ±0.29 |
83.83 ±4.81 |
82.17 ±1.30 |
85.17 ±2.24 |
2 |
84.33 ±1.33 |
83.67 ±2.85 |
83.33 ±1.85 |
85.00 ±1.53 |
84.33 ±2.19 |
84.00 ±1.53 |
82.67 ±0.66 |
83.00 ±2.00 |
84.33 ±0.29 |
83.83 ±1.96 |
83.00 ±1.26 |
84.00 ±1.04 |
3 |
82.67 ±2.05 |
84.00 ±1.53 |
75.67 ±1.45 |
85.67 ±3.18 |
85.00 ±1.53 |
85.00 ±3.51 |
74.00 ±1.53 |
87.00 ±0.58 |
83.83 ±2.05 |
84.50 ±2.52 |
74.83 ±1.45 |
83.66 ±1.59 |
4 |
87.33 ±5.04 |
87.33 ±3.18 |
83.33 ±1.85 |
85.00 ±1.53 |
85.33 ±1.67 |
85.66 ±1.45 |
83.33 ±1.85 |
87.00 ±3.22 |
86.33 ±2.33 |
86.50 ±2.02 |
83.33 ±0.93 |
86.00 ±2.18 |
5 |
84.67 ±1.33 |
83.33 ±1.85 |
80.67 ±1.85 |
82.67 ±1.77 |
82.33 ±2.60 |
81.67 ±3.18 |
81.00 ±4.04 |
86.33 ±3.12 |
83.50 ±1.89 |
82.50 ±2.36 |
80.83 ±2.60 |
84.50 ±1.26 |
6 |
81.00 ±2.52 |
80.67 ±3.53 |
79.33 ±1.85 |
90.33 ±1.77 |
82.33 ±2.60 |
81.67 ±3.18 |
81.00 ±4.04 |
86.33 ±3.12 |
83.50 ±1.89 |
82.50 ±2.36 |
80.83 ±2.60 |
84.50 ±1.26 |
7 |
84.67 ±4.34 |
77.33 ±2.60 |
74.33 ±1.85 |
88.33 ±1.33 |
82.00 ±2.89 |
76.00 ±2.52 |
75.33 ±1.20 |
90.33 ±1.67 |
83.33 ±3.18 |
76.67 ±2.52 |
74.83 ±1.46 |
89.33 ±1.67 |
8 |
84.00 ±1.00 |
75.67 ±1.85 |
78.33 ±1.85 |
89.67 ±1.33 |
85.67 ±1.85 |
74.67 ±1.20 |
79.00 ±3.00 |
88.67 ±1.20 |
84.83 ±1.30 |
75.17 ±1.30 |
78.67 ±2.21 |
89.17 ±1.17 |
9 |
81.33 ±2.90 |
77.00 ±2.64 |
73.67 ±2.40 |
88.00 ±1.53 |
84.00 ±1.53 |
74.00 ±1.15 |
74.00 ±1.53 |
90.00 ±1.53 |
82.67 ±2.05 |
75.50 ±1.89 |
73.83 ±1.73 |
89.00 ±1.32 |
10 |
81.33 ±2.90 |
77.00 ±2.64 |
73.67 ±2.40 |
88.00 ±1.53 |
84.00 ±1.53 |
74.00 ±1.15 |
74.00 ±1.53 |
90.00 ±1.53 |
82.67 ±2.05 |
75.50 ±1.89 |
73.83 ±1.73 |
89.00 ±1.32 |
Mean |
83.87b ±0.81 |
80.70c ±1.12 |
78.03d ±0.90 |
86.77a ±0.69 |
84.30b ±0.57 |
80.17c ±1.06 |
78.57c ±0.90 |
87.56a ±0.70 |
84.08b ±0.57 |
80.43c ±1.04 |
78.30d ±0.84 |
87.17a ±0.58 |
Gp 1: Conrol, Gp2: oxytocin, Gp 3: PGF2α and Gp4: GnRH.
Data regarding the percentage of morphologically abnormal spermatozoa are presented in table 7. As compared to control (6.35 ± 0.28%), all the treatment groups resulted in a significantly (P ≤ 0.05) lower percentage of abnormal spermatozoa (5.32 ± 0.24, 5.62 ± 0.31 and 4.52 ± 0.37% for oxytocin, PGF2α and GnRH groups, respectively).
Table 7: Effect of injection of oxytocin, PGF2α and GnRH on sperm abnormalities in rams (Mean ± S.D.).
Weeks |
Sperm abnormalities (%) |
|||||||||||
First ejaculate |
Second ejaculate |
Mean |
||||||||||
Gp 1 |
Gp 2 |
Gp 3 |
Gp 4 |
Gp 1 |
Gp 2 |
Gp 3 |
Gp 4 |
Gp 1 |
Gp 2 |
Gp 3 |
Gp 4 |
|
1 |
7.00 ±0.58 |
6.33 ±0.33 |
8.00 ±0.58 |
7.67 ±0.88 |
7.67 ±0.33 |
6.33 ±1.33 |
7.67 ±2.03 |
7.00 ±0.58 |
7.33 ±0.17 |
6.33 ±0.83 |
7.83 ±1.17 |
7.83 ±0.72 |
2 |
8.00 ±0.58 |
5.67 ±1.20 |
7.00 ±1.15 |
4.67 ±1.20 |
6.67 ±1.77 |
5.67 ±1.67 |
7.67 ±1.67 |
5.00 ±0.58 |
7.33 ±1.17 |
5.67 ±1.42 |
7.33 ±0.44 |
4.83 ±0.88 |
3 |
6.67 ±0.88 |
5.00 ±0.58 |
6.00 ±0.58 |
4.67 ±0.88 |
6.67 ±0.33 |
5.67 ±0.33 |
5.33 ±0.33 |
4.67 ±0.33 |
6.67 ±0.60 |
5.33 ±0.33 |
5.67 ±0.17 |
4.67 ±0.44 |
4 |
6.00 ±0.58 |
5.67 ±1.20 |
5.00 ±1.00 |
3.33 ±0.33 |
5.67 ±0.33 |
5.67 ±0.66 |
5.33 ±0.33 |
4.00 ±0.58 |
5.83 ±0.17 |
5.67 ±0.93 |
5.17 ±0.93 |
3.67 ±0.33 |
5 |
6.67 ±0.88 |
6.00 ±0.58 |
6.00 ±1.15 |
4.00 ±1.53 |
6.33 ±1.45 |
6.33 ±0.66 |
5.67 ±0.33 |
3.67 ±0.33 |
6.50 ±1.15 |
6.17 ±0.44 |
5.83 ±0.73 |
3.83 ±0.88 |
6 |
6.67 ±1.20 |
4.00 ±0.58 |
4.00 ±0.58 |
5.33 ±0.66 |
6.33 ±1.20 |
4.33 ±0.33 |
3.33 ±0.33 |
4.33 ±1.33 |
6.50 ±1.15 |
4.17 ±0.17 |
3.67 ±0.44 |
4.83 ±0.88 |
7 |
4.00 ±0.58 |
5.00 ±1.15 |
5.67 ±0.66 |
4.00 ±1.15 |
4.67 ±0.66 |
5.33 ±1.67 |
5.33 ±1.85 |
3.67 ±0.66 |
4.33 ±0.44 |
5.17 ±1.36 |
5.50 ±1.26 |
3.83 ±0.88 |
8 |
6.67 ±1.20 |
5.00 ±0.58 |
5.33 ±0.88 |
3.33 ±0.33 |
6.33 ±1.20 |
4.67 ±0.66 |
5.67 ±1.20 |
2.67 ±0.33 |
6.50 ±0.87 |
4.83 ±0.44 |
5.50 ±1.04 |
3.00 ±0.29 |
9 |
5.00 ±1.15 |
5.00 ±0.58 |
4.67 ±0.88 |
1.53 ±0.33 |
5.33 ±0.88 |
4.67 ±0.33 |
5.00 ±1.00 |
5.33 ±0.33 |
5.17 ±0.93 |
4.83 ±0.33 |
4.83 ±0.88 |
4.83 ±0.33 |
10 |
7.00 ±1.15 |
5.00 ±0.58 |
5.33 ±1.45 |
4.00 ±0.58 |
7.67 ±0.33 |
5.00 ±1.00 |
4.33 ±0.88 |
4.67 ±0.66 |
7.33 ±0.73 |
5.00 ±0.76 |
4.83 ±1.17 |
4.33 ±0.44 |
Mean |
6.37 a ±0.31 |
5.27ab ±0.24 |
5.70bc ±0.32 |
4.53 c ±0.32 |
6.33 a ±0.31 |
5.37ab ±0.29 |
5.53ab ±0.39 |
4.50 b ±0.27 |
6.35 a ±0.28 |
5.32 b ±0.24 |
5.62 b ±0.31 |
4.52 c ±0.37 |
Gp 1: Conrol, Gp2: oxytocin, Gp 3: PGF2α and Gp4: GnRH.
Table 8 illustrates frozen-thawed semen characteristics of rams of different treatment groups. There were no statistically significant (P ≤ 0.05) differences between the control and three treatment groups in the percentage of motile spermatozoa either at 0, 1, 2 or 3 hours post-thawing (just after thawing: 52.22 ± 2.06, 52.78 ± 1.09, 48.89 ± 1.38 and 53.89 ± 1.11% for groups 1-4, respectively; after one hour: 36.67 ± 1.07, 37.78 ± 1.88, 35.00 ± 1.18 and 38.33 ± 1.07% for groups 1-4, respectively; after 2 hours: 25.00 ± 1.07, 25.00 ± 1.44, 24.44 ± 1.30 and 25.56 ± 1.76 for groups 1-4, respectively; at 3rd hour post-thawing: 15.00 ± 2.89, 13.33 ± 2.04, 14.44 ± 2.26 and 14.44 ± 2.26% for groups 1-4, respectively). Also, there were no statistically significant (P ≤ 0.05) differences between the control and three treatment groups either in viability index (102.78 ± 5.26, 102.50 ± 4.81, 98.33 ± 3.93 and 105.28 ± 2.69 for groups 1-4, respectively) or in the percentage of spermatozoa with acrosomal defects (25.44 ± 1.44, 27.56 ± 1.61, 26.56 ± 1.07 and 26.78 ± 1.34% for groups 1-4, respectively).
Table 8: Frozen-thawed semen characteristics of rams injected with oxytocin, PGF2α and GnRH (Mean ± S.D.).
Items |
Week |
Gp1 |
Gp2 |
Gp3 |
Gp4 |
Fresh semen motility |
1 |
80.00 ± 0.00 |
81.67 ± 4.64 |
80.00 ± 1.44 |
83.33 ± 3.82 |
5 |
81.67 ± 2.21 |
80.83 ± 2.21 |
77.50 ± 2.89 |
83.33 ± 1.67 |
|
10 |
80.83 ± 2.21 |
73.33 ± 2.21 |
71.67 ± 2.21 |
87.50 ± 1.44 |
|
Mean |
80.83 ± 0.93 ab |
78.61 ± 2.09 b |
76.39 ± 1.07 b |
84.72 ± 1.14 a |
|
Motility just after thawing |
1 |
50.00 ± 2.80 |
53.33 ± 4.41 |
46.67 ± 1.67 |
53.33 ± 1.67 |
5 |
51.67 ± 3.33 |
53.33 ± 3.33 |
50.00 ± 2.88 |
51.67 ± 1.67 |
|
10 |
55.00 ± 5.06 |
51.67 ± 1.67 |
50.00 ± 2.88 |
56.67 ± 1.67 |
|
Mean |
52.22 ± 2.06 a |
52.78 ± 1.09 a |
48.89 ± 1.38 a |
53.89 ± 1.11 a |
|
Motility after 1 hr. |
1 |
36.67 ± 1.67 |
38.33 ± 4.41 |
36.67 ± 1.67 |
35.00 ± 2.88 |
5 |
35.00 ± 2.88 |
36.67 ± 4.41 |
35.00 ± 2.88 |
36.67 ± 1.67 |
|
10 |
38.33 ± 4.41 |
38.33 ± 1.67 |
33.33 ± 1.67 |
43.33 ± 1.67 |
|
Mean |
36.67 ± 1.07 a |
37.78 ± 1.88 a |
35.00 ± 1.18 a |
38.33 ± 1.07 a |
|
Motility after 2 hr. |
1 |
26.67 ± 1.67 |
25.00 ± 2.88 |
26.67 ± 1.67 |
21.67 ± 1.67 |
5 |
21.67 ± 3.33 |
23.33 ± 3.33 |
25.00 ± 2.88 |
23.33 ± 1.67 |
|
10 |
26.67 ± 3.33 |
26.67 ± 1.67 |
21.67 ± 1.67 |
31.67 ± 1.67 |
|
Mean |
25.00 ± 1.07 a |
25.00 ± 1.44 a |
24.44 ± 1.30 a |
25.56 ± 1.76 a |
|
Motility after 3 hr. |
1 |
18.33 ± 1.67 |
11.67 ± 1.67 |
16.67 ± 1.67 |
11.67 ± 1.67 |
5 |
11.67 ± 3.33 |
11.67 ± 1.67 |
15.00 ± 2.89 |
13.33 ± 1.67 |
|
10 |
15.00 ± 2.89 |
16.67 ± 1.67 |
11.67 ± 1.67 |
18.33 ± 1.67 |
|
Mean |
15.00 ± 2.89 a |
13.33 ± 2.04 a |
14.44 ± 2.26 a |
14.44 ± 2.26 a |
|
Viability index |
1 |
106.67 ± 8.98 |
101.67 ±10.83 |
103.33 ± 5.83 |
95.00 ± 3.82 |
5 |
94.17 ± 18.93 |
98.33 ± 10.93 |
100.00 ± 9.46 |
99.17 ± 5.07 |
|
10 |
107.50 ±12.50 |
107.50 ± 4.33 |
91.67 ± 7.07 |
121.67 ± 4.17 |
|
Mean |
102.78 ± 5.26a |
102.50 ± 4.81a |
98.33 ± 3.93 a |
105.28 ± 2.69a |
|
% of acrosomal defects |
1 |
25.33 ± 1.45 |
32.33 ± 2.90 |
24.67 ± 1.20 |
29.33 ± 2.19 |
5 |
26.67 ± 4.17 |
26.33 ± 1.77 |
28.00 ± 2.64 |
28.00 ± 2.08 |
|
10 |
24.33 ± 2.03 |
24.00 ± 1.00 |
27.00 ± 1.53 |
23.00 ± 1.15 |
|
Mean |
25.44 ± 1.44 a |
27.56 ± 1.61 a |
26.56 ± 1.07 a |
26.78 ± 1.34 a |
Gp 1: Conrol, Gp2: oxytocin, Gp 3: PGF2α and Gp4: GnRH.
As shown in table 9, injection of GnRH prior to semen collection resulted in significant increase in testosterone level when compared with control, oxytocin and PGF2αgroups (5.16 ± 0.11 vs. 4.34 ± 0.05, 4.37 ± 0.04 and 4.48 ± 0.11, respectively). Concerning the antioxidant activities exerted by ram semen of the different treatments groups (Table 9) represented by total antioxidant, superoxide dismutase and glutathione peroxidase, semen of PGF2αgroup has a significantly (P ≤ 0.05) higher antioxidant activities (0.35 ± 0.01, 302.18 ± 5.68 and 18.15 ± 0.92 mM/L, respectively) as compared with control (0.33 ± 0.01, 276.21 ±3.10 and 12.66 ± 0.81 mM/L, respectively), oxytocin group (0.33 ± 0.01, 277.90 ± 3.42 and 13.12 ± 1.11 mM/L, respectively) and GnRH group (0.32 ± 0.00, 224.83 ± 4.52 and 12.66 ± 1.01 mM/L, respectively).
Table 9: The levels of testosterone and antioxidant enzymes in the seminal plasma of rams injected with oxytocin, PGF2α and GnRH (Mean ± S.D.).
Items |
Week |
Gp1 |
Gp2 |
Gp3 |
Gp4 |
Testosterone (ng/ml) |
1 |
4.36 ± 0.11 |
4.50 ±0.02 |
4.54 ± 0.24 |
5.05 ± 0.09 |
5 |
4.28 ± 0.10 |
4.32 ± 0.03 |
4.42 ± 0.22 |
5.19 ± 0.11 |
|
10 |
4.38 ± 0.05 |
4.28 ± 0.05 |
4.48 ± 0.17 |
5.25 ± 0.13 |
|
Mean |
4.34 ± 0.05 b |
4.37 ± 0.04 b |
4.48 ± 0.11 b |
5.16 ± 0.11 a |
|
Total antioxidants (mM/L) |
1 |
0.35 ± 0.01 |
0.33 ± 0.02 |
0.35 ± 0.01 |
0.32 ± 0.01 |
5 |
0.32 ± 0.01 |
0.33 ± 0.01 |
0.35 ± 0.01 |
0.32 ± 0.01 |
|
10 |
0.33 ± 0.01 |
0.33 ± 0.01 |
0.36 ± 0.02 |
0.33 ± 0.01 |
|
Mean |
0.33 ± 0.01 b |
0.33 ± 0.01 b |
0.35 ± 0.01 a |
0.32 ± 0.00 b |
|
Superoxide dismutase (mM/L) |
1 |
280.24 ± 3.55 |
279.08 ± 7.44 |
301.59 ± 10.54 |
228.61 ± 13.89 |
5 |
272.61 ± 6.83 |
277.37 ± 4.87 |
301.59 ± 10.54 |
228.61 ± 13.98 |
|
10 |
275.77 ± 6.41 |
277.24 ± 7.75 |
300.75 ± 11.58 |
222.55 ± 4.52 |
|
Mean |
276.21 ± 3.10 b |
277.90 ± 3.42 b |
302.18 ± 5.68 a |
224.83 ± 4.52 c |
|
Glutathione peroxidase (mM/L) |
1 |
12.19 ± 2.23 |
12.99 ± 2.27 |
18.24 ± 1.10 |
12.09 ± 1.71 |
5 |
12.75 ± 1.73 |
13.31 ± 2.56 |
17.88 ± 1.69 |
12.24 ± 1.58 |
|
10 |
13.03 ± 1.01 |
13.04 ± 1.71 |
18.34 ± 2.45 |
12.42 ± 1.58 |
|
Mean |
12.66 ± 0.81 b |
13.12 ± 1.11 b |
18.15 ± 0.92 a |
12.66 ± 1.01 b |
Gp 1: Conrol, Gp2: oxytocin, Gp 3: PGF2α and Gp4: GnRH.
DISCUSSION
In flocks of sheep in which large numbers of spermatozoa must be collected from a few rams over a short period for artificial insemination (A.I.), a substantial increase in the output of spermatozoa per ejaculate per ram would be an advantage (Knight, 1974).The present study aimed to maximize the semen output from certain rams using different regimes as well as to study the effects of these treatments on quality, freezability and antioxidant activity of ram semen.
In the current study, repeated injection of oxytocin resulted in significant increase in semen volume and total number of spermatozoa per ejaculate. Similar results were recorded for oxytocin in rams (Knight and Lindsay, 1970; Knight, 1974; Voglmayr, 1975; Nicholson et al., 1999; Bozkurt et al., 2007) bulls (Sharma and Hays, 1973; Schefels and ElAzab, 1975; Berndtson and Igboeli, 1988; Palmer et al., 2004), buffalo (Ibrahim, 1988), rabbits (Fjellstrom et al., 1968), dogs (Hess, 2002), men (Rezk et al., 2004) and ostriches (Suttiyotin et al., 2012). In contrast, no detectable effect of oxytocin injection was found in rabbits (Agmo, 1975) and oligospermic men (Byrne et al., 2003).
In the present work, oxytocin did not alter sperm concentration, sperm mass activity or abnormal sperm rate in comparison to the control values. Similar findings were observed in rams by Bozkurt et al. (2007) and in bulls by Berndtson and Igboeli (1988). Similarly, the addition of oxytocin to bull (Gallagher and Senger, 1989) and stallion semen (Clough et al., 2006) was found to have no effect on sperm motility.
Circulating plasma concentrations of oxytocin increase during sexual arousal and ejaculation in bulls (Sharma and Hays, 1973) and humans (Carmichael et al., 1987). The action of oxytocin is mediated via activation of the oxytocin receptor present in the peritubular smooth muscle cells of the epididymis stimulating contractility in vivo (Hib, 1977) and in vitro (Filippi et al., 2002a). Oxytocin acts directly on smooth muscle cells throughout the entire epididymis and indirectly by stimulating the release of endothelin-1 from epithelial cells of the caput epididymidis (Peri et al., 1997; Filippi et al., 2002b). Endothelin-1 is a potent stimulator of epididymal contraction. Epididymal contractility stimulated by oxytocin may be important for the release of sperm stored in the cauda epididymidis, thereby enhancing sperm transport within the extragonadal ducts before and/or during ejaculation (Studdard et al., 2002).
In the current work, repeated injection of PGF2αresulted in significant increase in semen volume, sperm cell concentration and total number of spermatozoa per ejaculate. Similar results were recorded for PGF2αin rams (Azawi et al., 2011; Olfati et al., 2013) bulls (Hafs et al., 1974; Haynes et al., 1975; Marshall and Hafs, 1976; Masoumi et al., 2011; Titiroongruang et al., 2011), buffalo (Ibrahim, 1988), stallion (Kreider et al., 1981; McDonnell, 1992), rabbits (Hafs et al., 1974), dogs (Hess, 2002; Kustritz and Hess, 2007) and boars (Hashizume and Niwa, 1984; Estienne and Harper, 2004). In contrast, it was found that there was no effect of PGF2αtreatment on various semen characteristics in bulls (Berndtson et al., 1979) and boars (Levis and Reicks, 2005; Kozink, 2002).
In rams, the addition of PGF2α to semen increased the conception rate (Gustafsson et al., 1975) and increased the fertility of rams by more than 15%(Dimov and Georgiev, 1977).
The increase in the sperm number in the ejaculate following Cloprostenol administration is not probably due to an increased rate of spermatogenesis. Spermatogenesis is unaffected by the collection frequency or short-term PGF2αadministration (Johnson et al., 1970; Marshall and Hafs, 1976). It has been established that smooth muscle surrounding the epididymis contracts in response to PGF2αin other species (Hib and Oscar, 1978). Cauda epididymidis acts as a site of storage for mature spermatozoa. When the caudal epididymis contracts in response to PGF2α, mature spermatozoa are moved into the deferent duct where they are available for ejaculation (Masoumi et al., 2011).In addition to the effects of PGF2αon the smooth muscle of the epididymis, the testicular capsule also contracts in response to PGF2α(Free et al., 1980; Cosentino and Cockett, 1986).
In the present study, although GnRH improved motility and viability and morphologically normal spermatozoa of rams, it has no detectable effect on semen volume, sperm cell concentration and total number of spermatozoa per ejaculate. These results coincided with the findings of Hess (2002)in dogs. In contrary, Gabor et al. (1995) observed that repeated injection of GnRH provided valuable results of producing capacity of bull testes. Also, Braun et al. (1988) revealed the improvement of semen quality in adult bulls after the administration of GnRH. Garner et al. (1990) added that GnRH controls the production of gonadotropins, thereby having an orchestrating effect on the reproductive hormone cascade and spermatogenesis.
In the current investigations, repeated GnRH injection resulted in marked increase in testosterone level as compared to control. These results coincided with that recorded in bulls by Braun et al. (1988) and Gabor et al. (1995) and in dogs by Knol et al. (1993). The data pertaining to the effect of oxytocin on testosterone are controversial, because some researchers (Inaba et al., 1999) have reported that oxytocin treatment reduces the testosterone concentration in goats, whereas others (Nicholson et al., 1987) have reported that this hormone increases the release of testosterone in rats, and some (Nozdrachev et al., 1994; Kumar and Farooq, 1994; Bozkurt et al., 2007 in rat, mice and rams, respectively) have also documented that oxytocin does not alter the concentration of testosterone. In the present study, it was observed that the administration of oxytocin did not affect the levels of seminal plasma testosterone at any time compared to the control group. In the current work, injection of PGF2α had no effects on the level of testosterone. On contrary, plasma testosterone concentrations in bulls were increased after PGF2αinjection (Haynes et al., 1975; Kiser et al., 1976; Masoumi et al., 2011).
An unbalanced, excessive production of ROS and decreased level of antioxidant enzymes cause decreased sperm motility and viability, and increased sperm defects by initiating an oxidation chain reaction damaging proteins, lipids and DNA (Sikka, 2004; Aitken and Baker, 2004).Seminal plasma has an antioxidant system that seems to be very relevant to the protection of sperm. The sperm oxidative defence enzymes predominantly include superoxide dismutase, catalase, glutathione peroxidase and glutathione reductase (Sarlos et al., 2002).In the present study, PGF2α had beneficial effects on the antioxidant activities while repeated injection of oxytocin and GnRH had no deleterious effects on antioxidant activities in ram semen in terms of total antioxidants, superoxide dismutase and glutathione peroxidase levels in seminal plasma. To the best of our knowledge, no previous data are available about the effect of repeated injection of oxytocin, PGF2α and GnRH on the antioxidant activities of semen.
Concerning the post-thaw semen characteristics in the present work, all the treatment groups did not alter motility, viability and acrosomal integrity of the frozen-thawed ram semen. In agreement with these results, the others reported that the administration of PGF2αto bulls prior to ejaculation did not influence the motility of frozen-thawed spermatozoa (Marshall and Hafs, 1976; Masoumi et al., 2011). Berndtson and Igboeli (1988) mentioned that oxytocin did not impair the ability of bull spermatozoa to withstand freezing or thawing.
In conclusion, it was suggested that injection of PGF2α andoxytocinprior to semen collection may be useful when collecting ram semen for use in artificial insemination leading to increase in the semen output and increment in the total number of straws frozen. Moreover, repeated injection of them neither causes depletion of sperm reserves in rams nor alters the quality of fresh and frozen-thawed semen as well as they have no deleterious effects on the antioxidant activities of seminal plasma and testosterone level in rams.
REFERENCES
Agmo, A.J. (1975): Neurohypophysial hormones and the emission of semen in rabbits. J. Reprod. Fertil., 45, 243-248.
Aitken, R.J. and Baker, M.A. (2004): Oxidative stress and male reproductive biology. Reprod. Fertil. Dev., 16: 581–588.
Azawi, O.I.; Al-Khasab, A.T. and Al-Kadoo, N.N. (2011): Study on the effect of prostaglandin F2α treatment on semen characteristics and enzymatic activates of Awassi rams in breeding and non breeding seasons. Res. Opinions Anim. Vet. Sci., 1 (5): 318-324.
Berndtson, W. and Igboeli, G. (1988): Spermatogenesis, sperm output and seminal quality of Holstein bulls electroejaculated after administration of oxytocin. J. Reprod. Fertil., 82: 467–475.
Berndtson, W.; Chenoweth, P.; Seidel, G.; Pickett, B. and Olar, T. (1979): Influence of prostaglandin F2α on spermatogenesis, spermatozoal output, seminal quality, testosterone levels and libido of yearling beef bulls. J. Anim. Sci., 49: 736–742.
Bielanski, W.; Dudek, E.; Bittmar, A and Kosiniak, K. (1982): Some characteristics of common abnormal forms of spermatozoa in highly fertile stallions. J. Reprod. Fertil. Suppl., 32: 21–26.
Blom, E. (1950): Eine schnellfarb methode mit eosin und nigrosin zur unterscheidung von lebenden und toten spermien. Wien Tierarztl Wschr, 37: 441–442.
Bozkurt, T.; Gaffari, T.R. and Seyfettin, G.R. (2007): Effects of Exogenous Oxytocin on Serologic and Seminal Steroids and Semen Characteristics in Rams. Turk. J. Vet. Anim. Sci.; 31(5): 303-309.
Braun, J.; Brem, G. and Schams, D. (1988): Reproductive functions in monozygotic bulls derived from embryo-microsurgery. In: Proceedings of VI. World Conf. of Anim. Prod. Helsinki., pp: 577-580.
Bygdeman, M. (1981): Effects of prostaglandins on the genital tract. Acta. Vet. Scand., 77 (Suppl.): 47–54.
Byrne, M.M.; Rolf, C.; Depenbusch, M.; Cooper, T.G. and Nieschlag, E. (2003): Lack of effect of a single i.v. dose of oxytocin on sperm output in severely oligozoospermic men. Human Reprod., 18 (10): 2098-2102.
Carmichael, M.S.; Humbert, R. and Dixen, J. (1987): Plasma oxytocin increases in the human sexual response. J. Clin. Endocrinol. Metab., 64: 27–31.
Clough, C.J.; Campbell, M.L.H. and Matson, T. (2006): The effect of inclusion of oxytocin in semen extender on spermatozoal motility. Anim. Reprod. Sci., 94: 132–134.
Cornwell, J.; Koonce, K. and Kreider, J. (1974): Effect of prostaglandin F2α on seminal characteristics of the stallion. J. Anim. Sci., 38: 226 (Abst.).
Cosentino, M.J. and Cockett, A.T. (1986): Structure and function of the epididymis. Urol. Res., 14: 229-240.
Costat Computer Program copyright (1986): Version3.03 copyright software.
Dimov, V. and Georgiev, G. (1977): Ram semen prostaglandin concentration and its effect on fertility J. Anim. Sci., 44 (6): 1050-1054.
Estienne, M.J. and Harper, A.F. (2004): PGF2α facilitates the training of sexually active boars for semen collection. Theriogenology, 54: 1087-1092.
Evans, G. and Maxwell, W.M.C. (1986): Salamon's Artificial Insemination of Sheep and Goats. Butterworth, Sydney.
Filippi, S.; Luconi, M.; Granchi, S.; Vignozzi, L.; Bettuzzi, S.; Tozzi, P.; Forti, G. and Maggi, M. (2002a): Estrogens, but not androgens, regulate expression and functional activity of oxytocin receptor in rabbit epididymis. Endocrinol., 143: 4271-4280.
Filippi, S.; Vannelli, G.B.; Granchi, S.; Luconi, M.; Crescioli, C.; Mancina, R.; Natali, A.; Brocchi, S.; Vignozzi, L. and Bencini, E. (2002b): Identification, localization and functional activity of oxytocin receptors in epididymis. Mol. Cell. Endocrinol., 193: 89-100.
Fjellstrom, D.; Kihlstrom, J. and Melin, P. (1968): The effect of synthetic oxytocin upon seminal characteristics and sexual behaviour in male rabbits. J. Reprod. Fertil., 17: 207–209.
Frayne, J. and Nicholson, H. (1998): Localization of oxytocin receptors in the human and macaque monkey male reproductive tracts: evidence for a physiological role in the male. Mol. Hum. Reprod., 4: 527–532.
Free, M.J.; Jaffe, R.A. and Morford, D.E. (1980): Sperm transport through the rete testis in anesthetized rats: role of the testicular capsule and effect of gonadotropins and prostaglandins. Biol. Reprod., 22: 1073-1078.
Gabor, G.; Mayes, Z.; Sziicsz, E. and Banary, I. (1995): Relationship among testosterone response to GnRH administration, testes size and sperm parameters in Holstein-Friesian bulls. Theriogenology, 43: 1317-1324.
Gallagher, G.R and Senger, P.L. (1989): Effect of phenylephrine, ergonovine, oxytocin and norephrine as an extender ingredient on viability of bovine spermatozoa. J. Anim. Sci., 67 (6): 1573–1576.
Garner, L.L.; Campbell, G.T. and Blake, C.A. (1990): Luteinizing hormone (LH)-releasing hormone: chronic effects on LH and follicle-stimulating hormone cells and secretion in adult male rats. Endocrinology, 126 (2): 992-1000.
Hafs, H.D.; Louis, T.M.; Waters, R.J.; Stellflug, J.N. and Haynes, N.B. (1974): Increased sperm output of rabbits and bulls treated with PGF2α. Prostaglandins, 8: 417-422.
Hashizume, T. and Niwa, T. (1984): Effect of administration of PGF2α on the properties of sperm rich fraction of boar semen. Japan J. Anim. Reprod., 30: 182-185.
Haynes, N.B.; Hafs, H.D.; Waters, R.J.; Mannas, J.G. and Riley, A. (1975): Stimulatory effect of PGF2α on the plasma concentration of testosterone in bulls. J. Endocrinol., 66: 329-338.
Hess, M. (2001): The effects of prostaglandin-F2_, oxytocin and gonadotropin releasing hormone on ejaculate characteristics in the dog, Proc. Soc. Theriogenology, 15.
Hess, M. (2002): The effects of prostaglandin F2α, oxytocin and gonadotropin releasing hormone on ejaculate characteristics in the dog. Master Thesis, Virginia Polytechnic Institute and State University, USA.
Hib, J. (1977): The “in vivo” effects of oxytocin and vasopressin on spontaneous contractility of the rat epididymis. Int. J. Fertil., 22: 63–64.
Hib, J. and Oscar, P. (1978): Effects of prostaglandin and indomethacin on rat epididymal responses to norepinipherine and acetylcholine. Arch. Androl., 1: 43-47.
Ibrahim, M. (1988): Influence of oxytocin and prostaglandin on semen characteristics and process of ejaculation in buffalo bulls. Acta. Vet. Hung., 82: 3–10.
Inaba, T.; Nakayama, Y.; Tani, H.; Tamada, H.; Kawate, N. and Sawada, T. (1999): Oxytocin gene expression and action in goat testis. Theriogenology, 52: 425-434.
Johnson, A.D.; Gomes, W.R. and Van Demark, N.L. (1970): “The Testis”. Academic Press.
Khalifa, T.A.A. (2001): Effect of some antioxidants on viability of preserved buffalo and ram semen. Ph.D. Thesis, Fac. Vet. Med. Cairo Univ.
Kiser, T.E.; Hafs, H.D. and Oxender, W.D. (1976): Increased blood LH and testosterone after administration of PGF2α in bulls. Prostaglandins, 11: 545-553.
Knight, T.W. and Lindsay, D.R. (1970): Short- and long term effects of oxytocin on quality and quantity of semen from rams. J. Reprod. Fert., 21: 523-529.
Knight, T.W. (1974): The effect of oxytocin and adrenaline on the semen output of rams. J. Reprod. Fertil., 39: 329-336.
Knol, B.W.; Dieleman, S.J. and Bevers, M.M. (1993): GnRH in the male dog: dose response relationships with LH and testosterone. J. Reprod. Fertil., 98: 159.
Koracevic, D. and Koracevic, G. (2001): J. Clin. Path., 54: 356-361.
Kozink, D.M. (2002): Enhancing boar reproductive performance for purposes of artificial insemination. M.V.Sc. Thesis, Georgia Univ., U.S.A.
Kreider, J.L.; Ogg, W.L. and Turner, J.W. (1981): Influence of prostaglandin F2alpha on sperm production and seminal characteristics of the stallion. Prostaglandins, 22: 903–913.
Kumar, A. and Farooq, A. (1994): Effect of oxytocin on the concentration of fructose in the accessory glands of mouse. Life Sciences, 55 (l):19-24.
Kustritz, M.V. and Hess, M. (2007): Effect of administration of prostaglandin F2alpha or presence of an estrous teaser bitch on characteristics of the canine ejaculate. Theriogenology, 67: 255–258.
Levis, D.G. and Reicks, D.L. (2005): Assessment of sexual behavior and effect of semen collection, pen design and sexual stimulation of boars on behavior and sperm output—a review. Theriogenology, 63: 630–642.
Marshall, C. and Hafs, H. (1976): Sperm output and quality after PGF in bulls. J. Anim. Sci., 43, 296 (Abst.).
Maruyama, Y. (1987): Sex-steroid-binding plasma protein, testosterone, oestradiol and DHEA in prepuberty and puberty. Acta Endocronologica, 114: 60-67.
Masoumi, R.; Towhidi, A.; Javaremi, A.N.; Nabizadeh, H. and Zhandi, M. (2011): Influence of PGF2α on semen quality and libido in Holstein bulls. Turk. J. Vet. Anim. Sci., 35 (1): 1-6.
McDonnell, S. (1992): Ejaculation physiology and dysfunction. Vet. Clin. N. Am. Equine Prac., 8: 57–70.
Mekonnen, G.; Boland, M. and Gordon, I. (1989): The effect of prostaglandin on semen production and libido in the ram. Irish Vet. J., 1 (1-2): 56-62.
Milovanov, V.K. (1962): Biology of reproduction and artificial insemination of farm animals. Monograph. Selkohz. Lit. J. and Plakatov, Moscow.
Murphy, M.R.; Seckl, J.R.; Burton, S.; Checkley, S.A. and Lightman, S.L. (1987): Changes in oxytocin and vasopressin secretion during sexual activity in men. J. Clin. Endocr. Metab., 65:738-741.
Nicholson, H.; Parkinson, T. and Lapwood, K. (1999): Effects of oxytocin and vasopressin on sperm transport from the cauda epididymis in sheep. J. Reprod. Fertil., 117: 299–305.
Nicholson, H.D.; Worley, R.T.S.; Guldenaar, S.E.F. and Pickering, B.T. (1987): Ethan-1,2-dimethanesulphanate reduces testicular oxytocin content and seminiferous tubule movements in the rat. J. Endocrinol., 112: 311-316.
Nishikimi, M.; Rao, N.A. and Yogi, K. (1972): Bioch. Biophys. Res. Common., 46: 849-854.
Nozdrachev, A.D.; Kovalenk, R.I.; Chernysheva, M.P. and Semenova, E.P. (1994): The effect of the intraventricular administration of oxytocin on the functional activity of the epiphysis, adrenals and gonads and on the behavior of rats. Fiziol. Zh. I. I.M. Sechenova, 80: 88-97.
Olfati, A.; Moghaddam, G.H.; Daghigh, H. and Shabankareh, H.K. (2013): Effects of prostaglandin F2α treatment on semen characteristics of crossbred rams in the non-breeding season. J. Cell & Anim. Biol., 7 (2): 16-20.
Paglia, D.E. and Valentine, W.N. (1967): J. Lab. Clin. Med., 70: 158-169.
Palmer, C.W.; Amundson, S.D.; Brito, L.F.; Waldner, C.L. and Barth, A.D. (2004): Use of oxytocin and cloprostenol to facilitate semen collection by electroejaculation or transrectal massage in bulls. Anim. Reprod. Sci., 80: 213-223.
Peri, A.; Fantoni, G.; Granchi, S.; Vannelli, G.B.; Barni, T.; Amerini, S.; Pupilli, C.; Barbagli, G.; Forti, G. and Serio, M. (1997): Gene expression of endothelin-1, endothelin-converting enzyme-1, and endothelin receptors in human epididymis. J. Clin. Endocrinol. Metab., 82, 3797-3806.
Rezk, A.Y.; Al-Inany, H. and Bedaiwy, M. (2004): Multiple intravenous oxytocin injection may yield sperm in azoospermic men scheduled for TESE. Middle East Fert. Soc. J., 9: 238-241.
Sarlos, P.; Molnar, A.; Kokai, M. and Ratky, G. (2002): Comparative evaluation of the effect of antioxidants in the conservation of ram semen. Acta Veterinaria Hungarica, 50: 235–245.
Schefels, W. and ElAzab, A. (1975): The effect of oxytocin on ejaculate composition in the bull. Theriogenology, 4: 134, Abstr.
Sharma, O.P. and Hays, R.L. (1973): Release of an oxytocic substance following genital stimulation in bulls. J. Reprod. Fert., 35: 359-362.
Sikka, S.C. (2004): Role of oxidative stress and antioxidants in andrology and assisted reproductive technology. J. Androl., 25: 5–18.
Studdard, P.W.; Stein, J. L. and Cosentino, M.J. (2002): The effects of oxytocin and arginine vasopressin in vitro on epididymal contractility in the rat. Int. J. Androl., 25: 65-71.
Suttiyotin, P.; Khumpim, P.; Kimsakulvech, S. and Eurlaphan, C. (2012): Improvement of semen quantity and quality in Ostriches by oxytocin injection before semen Collection. Suranaree J. Sci. Technol., 19 (1): 9-14.
Titiroongruang, J.; Hirunpattarawong, P.; Sophonpattana, P.; Singlor, J. and Tummaruk, P. (2011): Effects of Prostaglandin F2α on Serum Testosterone and Semen Output in Holstein Friesian Bulls in Tropical Climate. Thai. J. Vet. Med., Suppl. 41:159-160.
Voglmayr, J.K. (1975): Output of spermatozoa and fluid by the testis of the ram and its response to oxytocin. J. Reprod. Fert., 43: 119-122.
Wells, M.E. and Awa, O.A. (1970): New technique for assessing acrosomal characteristics of spermatozoa. J. Dairy sci., 53: 227-232.
Whittington, K.; Assinder, S.; Parkinson, T.; Lapwood, K. and Nicholson, H. (2001): Function and localization of oxytocin receptors in the reproductive tissues of rams. Reproduction, 122: 317–325.
دراسة تأثير البروستاجلاندين F2a أو الأوکسيتوسين أو الهرمون المحرر للحاثة المنسلية على خصائص قذفة السائل المنوى للکباش وقابلية السائل المنوى للتجميد
ضياء الدين عبد المؤمن البدرى ، فاتنإبراهيم جبر ، منى حامد شاکر
تهدف هذة الدراسة إلى زيادة حجم القذفة وترکيز الحيوانات المنوية المجمعة من الکباش بإستخدام الأوکسيتوسين أو البروستاجلاندين F2a أو الهرمون المحرر للحاثة المنسلية مع دراسة تأثير هذة المعاملات على خصائص السائل المنوى الطازج والمجمد للکباش ودراسة تأثيرهم على مستوى مضادات الأکسدة بالسائل المنوى. تم تقسيم عدد 12 کبش برقى إلى 4 مجموعات متساوية: الأولى ضابطة تم حقنها بالعضل بمحلول ملح فسيولوجى قبل تجميع السائل المنوى ب 30 دقيقة والمجموعة الثانية تم حقنها بالوريد ب 10 وحدات دولية من الأوکسيتوسين قبيل التجميع ب 10 دقائق والمجموعة الثالثة حقنت بالعضل ب 250 ميکروجرام من الکلوبروستينول قبل التجميع ب 30 دقيقة والمجموعة الرابعة حقنت بالوريد ب 50 ميکروجرام من الجونادورولين 60 دقيقة قبل تجميع السائل المنوى. تم تجميع قذفتى سائل منوى من الکباش مرة واحدة أسبوعيا على مدار 10 أسابيع وفى الأسبوع الأول والخامس والعاشر تم تجميد السائل المنوى للکباش مع قياس مستويات التستوستيرون وإنزيمات مضادات الأکسدة فى بلازما السائل المنوى. وقد أظهرت النتائج أن حقن البروستاجلاندين F2a والأوکسيتوسين أديا إلى زيادة ملحوظة (P ≤ 0.05) فى حجم القذفة وفى العدد الکلى للحيوانات المنوية بالقذفة طوال فترة التجربة وبدون حدوث تغيرات ملحوظة فى خصائص السائل المنوى الطازج والمجمد. کما أن البروستاجلاندين F2a والأوکسيتوسين لم يؤثرا سلبا على مستويات التستوستيرون ومضادات الأکسدة الکلية والسوبر أوکسيد ديسميوتاز والجلوتاثيون بيروکسيدازز وفى المقابل, أدى حقن الهرمون الهرمون المحرر للحاثة المنسلية إلى زيادة مستوى التستوستيرون لکنة لم يؤدى إلى زيادة حجم القذفة وترکيز الحيوانات المنوية بها. نستخلص من هذة الدراسة أن تکرار حقن البروستاجلاندين F2a أو الأوکسيتوسين قبيل تجميع السائل المنوى له فائدة کبيرة عندما يتم التجميع من الکباش للأستخدام فى التلقيح الأصطناعى لأن ذلک يزيد من عدد الحيوانت المنوية المتحصل عليها بدون تغيير ملحوظ فى خصائص السائل المنوى الطازج والمجمد بالإضافة لعدم وجود أثار سلبية على مستوى مضادات الأکسدة والتستوستيرون فى بلازما السائل المنوى.